Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Investigation
|
May 19, 2022
Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency
Nicole Frumento, Alexis Figueroa, Tingchang Wang, et al.
Science Advances
|
August 8, 2018
CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans
Ramy El-Diwany, Mary Soliman, Sho Sugawara, et al.
Cell Host & Microbe
|
November 16, 2018
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection
Valerie J Kinchen, Muhammad N Zahid, Andrew I Flyak, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 3, 2020
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Clinton O Ogega, Nicole E Skinner, Paul W Blair, et al.
The Journal of General Virology
|
January 13, 2026
Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent
Jessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, et al.
Immunity
|
March 22, 2024
Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance
Clinton O Ogega, Nicole E Skinner, Marta V Schoenle, et al.
The Journal of Clinical Investigation
|
February 11, 2021
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Clinton O Ogega, Nicole E Skinner, Paul W Blair, et al.
Biorxiv : the Preprint Server for Biology
|
January 16, 2026
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope
Harry T Paul, Jessica L Mimms, Hanna Aboueid, et al.
JCI Insight
|
May 5, 2017
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
Justin R Bailey, Andrew I Flyak, Valerie J Cohen, et al.
Journal of Hepatology
|
July 10, 2024
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone
Juthika Kundu, Hoa T Le, Michael Logan, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Investigation
|
May 19, 2022
Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency
Nicole Frumento, Alexis Figueroa, Tingchang Wang, et al.
Science Advances
|
August 8, 2018
CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans
Ramy El-Diwany, Mary Soliman, Sho Sugawara, et al.
Cell Host & Microbe
|
November 16, 2018
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection
Valerie J Kinchen, Muhammad N Zahid, Andrew I Flyak, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 3, 2020
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Clinton O Ogega, Nicole E Skinner, Paul W Blair, et al.
The Journal of General Virology
|
January 13, 2026
Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent
Jessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, et al.
Immunity
|
March 22, 2024
Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance
Clinton O Ogega, Nicole E Skinner, Marta V Schoenle, et al.
The Journal of Clinical Investigation
|
February 11, 2021
Durable SARS-CoV-2 B cell immunity after mild or severe disease
Clinton O Ogega, Nicole E Skinner, Paul W Blair, et al.
Biorxiv : the Preprint Server for Biology
|
January 16, 2026
mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope
Harry T Paul, Jessica L Mimms, Hanna Aboueid, et al.
JCI Insight
|
May 5, 2017
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
Justin R Bailey, Andrew I Flyak, Valerie J Cohen, et al.
Journal of Hepatology
|
July 10, 2024
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone
Juthika Kundu, Hoa T Le, Michael Logan, et al.
Page
of 9